Etihad Cargo - HOPE Consortuim
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

30

Nov 2020

Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines to create a new generation of transformative medicines for patients announced a supply agreement with the UK government for an additional million doses of mRNA

27

Nov 2020

Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda

Egle Therapeutics SAS Egle an emerging biotechnology company focused on developing firstin class immunotherapies targeting immune suppressor regulatory Tcells Tregs for oncology and autoimmune diseases today announces that it has achieved the first milestone in its strategic research alliance with T...

27

Nov 2020

Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders

Biogen Incand Sage Therapeutics Inc announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone SAGE for major depressive disorder MDD postpartum depression PPD and other psychiatric disorders and SAGE for essential tremor and other...

26

Nov 2020

RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19

RedHill Biopharma Ltd a specialty biopharmaceutical company today announced partnerships with two leading USbased manufacturers for largescale manufacturing of opaganib These collaborations further advance ongoing preparations to support potential emergency use applications for opaganib to treat sev...

press releasesRead more...

30

Nov 2020

Veritas offers genome analysis to predict a person's response to COVID-19

Genetic factors can determine a persons possible response to infection regardless of age and previous illnesses By analyzing it we can better understand why certain people have little or no symptoms while others experience severe complications

27

Nov 2020

SAL Unveils New Pharma and Perishable facilities in Riyadh in time for Covid vaccines distribution

Saudi Arabian Logistics Company SAL Saudi Arabias leading cargo ground handler and logistics provider is pleased to announce the unveiling of its new pharma and perishable facilities at the Cargo Village in Riyadh specializing in perishables and all types of pharmaceuticals including the muchawaited...

27

Nov 2020

Eppendorf SmartBlock™ for Cell Thawing: Reproducible and Reliable Process

Eppendorf offers now a further building block in supporting scientists with tailored solutions for the daily lab routine Controlled and reliable cell thawing is mandatory for further downstream experiments in every cell handling lab Although waterbath based or even manual thawing of cells is still c...

27

Nov 2020

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

Rhythm Pharmaceuticals Inc a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity announced that the US Food Drug Administration FDA has approved IMCIVREE setmelanotide for chronic weight management in adult and pediatric...

EventsRead more...

30 - 01

Nov 2020

30 - 03

Nov 2020

30 - 03

Nov 2020

30 - 02

Nov 2020

LEAP HR Emerging Biopharma 2020

Hilton Boston Back Bay

TOP ARTICLES

  • 2

    Personalised Therapy

    Drugs can be formulated in the form of tablets pellets emulsion cream and many others for patient consumption...

KNOWLEDGE BANK

  • Interviews

    Datamonitor

    Analyst

    include the changing patent laws as countries aim to become more TRIPS compliant with India updating its law recently and China in the process of doing so through the WTO Increasing globalization of the generics market with Indian companies becoming involved in Europe and the US and vice versa will also provide an opportunity for generics companies
  • Articles

    Advanced Nanobots for ‘Programmed’ Biomedical Applications

    The idea of nanobots that could perform programmed tasks at targeted sites by traveling through biological fluids is no more in science fiction now Recent development in the field of nanotechnology provides the scope of designing miniaturised tiny nanobots which are even smaller than the dimension of biological cells

  • Techno Trends

    Asterias’ Novel Immunotherapy Treatment AST-VAC2 Moves into Clinical Trials

    The charity Cancer Research UK and its commercial arm Cancer Research Technology CRT have entered into an agreement with US biotech firm Asterias Biotherapeutics a subsidiary of BioTime Inc to conduct clinical trials of Asterias novel immunotherapy treatment ASTVAC in subjects with nonsmall cell lung cancer ASTVAC is a nonpatient specific allogeneic canc

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...